Key points are not available for this paper at this time.
Introduction Up to 25% of patients with HPV-positive oropharyngeal carcinoma (HPV+OPSCC) develop recurrence. Biomarkers for the early identification of this subcohort are missing. The aim of this study was to identify a transcriptome (mRNA)-based expression profile associated with the development of recurrence in patients with HPV+OPSCC.
Suchan et al. (Fri,) studied this question.